Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tivoxavir marboxil in mild to moderate influenza
NCT07371650Phase 2Active, not recruiting
- Sponsor
- Traws Pharma, Inc.
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tivoxavir marboxil in influenza, sponsored by Traws Pharma, Inc.. Started Dec 2025; status: active, not recruiting.
02
Drugs
tivoxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07371650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07371650.